Aerie Pharma's Rhopressa maintains safety profile over six months while matching timolol [Seeking Alpha]
Aerie Pharmaceuticals, Inc. (AERI)
Last aerie pharmaceuticals, inc. earnings: 2/20 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.aeriepharma.com/investor-relations
Company Research
Source: Seeking Alpha
Top-line data from the Phase 3 Rocket 4 study showed Aerie Pharmaceuticals' (NASDAQ: AERI ) Rhopressa (netarsudil ophthalmic solution) maintained its safety characteristics while sustaining its non-inferiority to timolol over a six-month period. The trial assessed Rhopressa for lowering intraocular pressure in patients with glaucoma or ocular hypertension. The results will support a European marketing application. Its U.S. marketing application is currently under FDA review. Management will host a conference call at 5:00 pm ET to discuss the results. Previously: Aerie Pharmaceuticals completes enrollment of Rocket 4 Phase 3 clinical trial of Rhopressatm 0.02% (June 16, 2016) Now read: Industry Snapshot: Setting Sights On Glaucoma Drug Makers »
Show less
Read more
Impact Snapshot
Event Time:
AERI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AERI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AERI alerts
High impacting Aerie Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics